Medical Advocates
Azvudine

Main Page

New and Noteworthy
Journal Abstracts, Papers, and Commentaries
News Releases

ARV Investigational Drugs Main Page

Home Page

Last Update: March 11, 2015
Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

New and Noteworthy

August 2014

A WEEK-IN-REVEW FEATURED REPORT
FULL-TEXT ARTICLE
Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro.
Wang RR, Yang QH, Luo RH, et al PLoS One. 2014 Aug 21;9(8):e105617

Journal Papers, Abstracts, and Commentaries

A WEEK-IN-REVEW FEATURED REPORT
FULL-TEXT ARTICLE
Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro.
Wang RR, Yang QH, Luo RH, et al
PLoS One. 2014 Aug 21;9(8):e105617
Paper

News Releases

HIV RT Inhibitor Azvudine Received IND Approval
Granlen – May 18, 2013

ARV Investigational Drugs Main Page

Home Page

Azvudine